Aurora Cannabis Inc. (ACB,ACB.TO) Tuesday announced the confidential settlement with Canada-based Willow Biosciences Inc., resolving the ongoing patent litigation between the two parties.
Further, Aurora affirmed its commitment to enforce and defend intellectual property rights.
Miguel Martin, Chief Executive Officer of Aurora noted that the negotiated settlement ensures its Canadian cannabis-related patent rights.
Aurora, serving both the medical and consumer markets, commenced a patent infringement action in July 2021, alleging that Willow's biosynthetic process for synthesizing cannabinoids infringed Aurora's exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council.
The technology of the asserted patents was invented by Anandia, co-founder and former chief science officer at Aurora, Jonathan Page, and his colleagues, identifying key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.